Effective August 1, 2024, this database was discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.
Spotlight
The Path to Genomic Screening—Far From Simple, but the Journey Has Begun
From the article: "Today’s genomic technology introduces a multitude of assays that could be deployed in health care: diagnostic testing of patients with suspected monogenic conditions, polygenic risk prediction for common diseases, pharmacogenomic analysis for drug-gene interactions, analysis of tumors for targetable somatic sequence variations, and noninvasive screening for prenatal chromosomal disorders or occult cancer. Alongside these approaches we must also grapple with screening of the ostensibly healthy population for monogenic diseases of newborns, children, and adults with either targeted or genome-scale sequencing. "
Screening Familial Risk for Hereditary Breast and Ovarian Cancer
From the abstract: "In a large health system, how many ungenotyped patients meet family history genetic testing criteria for hereditary breast and ovarian cancer? In this cross-sectional analysis, 2.9% of patients had no evidence of prior genetic testing but had electronic health records indicating they met family history criteria. These criteria were associated with significantly increased prevalence of genetic risk variants among 38?003 genotyped patients. These findings suggest that substantial gaps exist in identifying and testing patients meeting family history criteria for hereditary breast and ovarian cancer, and other methods may be needed to close these gaps. "
Harnessing cancer genomes for precision oncology
From the abstract: "Precision oncology has just received a boost: a report on the prevalence of mutations in cancer driver genes based on whole genome sequencing of 10,000 clinical cases. The challenge ahead lies in how to explore the data to accelerate new discoveries in cancer biology while advancing precision oncology. "
Advancing Genomic Cancer Medicine in Rural and Underserved States
From the article: "In the evolving landscape of oncology, the integration of powerful genomic technologies into practice has ushered in a new era of precision cancer medicine. Complex genomic information such as mutational analyses, transcriptional signatures, and polygenic risk scores have become key diagnostics guiding therapeutic decisions and management of inherited cancer risk. However, the expertise to interpret these data for clinical decision-making remains constrained and is a significant challenge for community oncologists, especially those in rural regions and in medically underserved areas. While physical access to these tests is readily available, poor access to interpretive expertise has become the key limiting factor. "
Latest
News and Publications
Demir Emre, et al. Medicine 2025 0 0. (3) e41319
Optimizing mRNA translation efficiency through rational 5'UTR and 3'UTR combinatorial design.
Li Ting, et al. Gene 2025 0 0. 149254
Advancing COVID-19 Treatment: The Role of Non-covalent Inhibitors Unveiled by Integrated Machine Learning and Network Pharmacology.
Qadir Saba, et al. Current pharmaceutical design 2025 0 0.
Better Outcomes for Ovarian Cancer Associated With the Detection of Anti-EBV TCR CDR3s: Potential Relevance to Diffuse Large B-Cell Lymphoma.
Goel Nandini, et al. American journal of reproductive immunology (New York, N.Y. : 1989) 2025 0 0. (1) e70046
Linking The Cancer Imaging Archive and GenBank to the National Clinical Cohort Collaborative.
Baghal Ahmad, et al. Learning health systems 2025 0 0. (1) e10457
Polarized Calu-3 Cells Serve as an Intermediary Model for SARS-CoV-2 Infection.
Harbach Sarah L, et al. Methods in molecular biology (Clifton, N.J.) 2025 0 0.
Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019.
Yang Feixiang, et al. Prostate international 2025 0 0. (3) 167-177
Recent developments and future directions in point-of-care next-generation CRISPR-based rapid diagnosis.
Hassan Youssef M, et al. Clinical and experimental medicine 2025 0 0. (1) 33
Equivocating and Deliberating on the Probability of COVID-19 Infection Serving as a Risk Factor for Lung Cancer and Common Molecular Pathways Serving as a Link.
Amara Abdelbasset, et al. Pathogens (Basel, Switzerland) 2025 0 0. (12)
IL-18 and IL-18BP: A Unique Dyad in Health and Disease.
Novick Daniela, et al. International journal of molecular sciences 2025 0 0. (24)
Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures.
Gonzalez-Carmona Maria A, et al. International journal of molecular sciences 2025 0 0. (24)
SARS-CoV-2 Spike Protein Amplifies the Immunogenicity of Healthy Renal Epithelium in the Presence of Renal Cell Carcinoma.
Somova Maryna, et al. Cells 2025 0 0. (24)
SEMdag: Fast learning of Directed Acyclic Graphs via node or layer ordering.
Grassi Mario, et al. PloS one 2025 0 0. (1) e0317283
State of Knowledge About Thyroid Cancers in the Era of COVID-19-A Narrative Review.
Bronowicka-Szydelko Agnieszka, et al. Biomedicines 2025 0 0. (12)
Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine.
Yang Seonkyeong, et al. JAMA neurology 2025 0 0.
An automated privacy-preserving self-supervised classification of COVID-19 from lung CT scan images minimizing the requirements of large data annotation.
Chowa Sadia Sultana, et al. Scientific reports 2025 0 0. (1) 226
Recent advances in mRNA-based therapeutics for neurodegenerative diseases and brain tumors.
Yang Lizhi, et al. Nanoscale 2025 0 0.
Alterations in Cellular Gene Expression Due to Co-Infection With Kaposi's Sarcoma-Associated Herpesvirus and SARS-CoV-2: Implications for Disease Severity.
Chen Jungang, et al. Journal of medical virology 2024 0 0. (1) e70149
Recommendations to reduce and prevent negative health outcomes and healthcare costs among night shift nurses: An AAN consensus paper.
Baldwin Carol M, et al. Nursing outlook 2024 0 0. (1) 102344
Survival prediction of glioblastoma patients using machine learning and deep learning: a systematic review.
Poursaeed Roya, et al. BMC cancer 2024 0 0. (1) 1581
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SM.
Kamposioras Konstantinos, et al. Current oncology (Toronto, Ont.) 2024 0 0. (12) 7903-7913
Changes in Risk Tolerance for Ovarian Cancer Prevention Strategies during the COVID-19 Pandemic: Results of a Discrete Choice Experiment.
Egleston Brian L, et al. Medical decision making : an international journal of the Society for Medical Decision Making 2024 0 0. 272989X241302829
Artificial Intelligence Assessment of Chest Radiographs for COVID-19.
Sasaki Koji, et al. Clinical lymphoma, myeloma & leukemia 2024 0 0.
Neutralizing antibodies against SARS-CoV-2 of vaccinated healthcare workers in Taiwan.
Priyambodo Seto, et al. Annals of medicine 2024 0 0. (1) 2442533
STING-Activating Polymers Boost Lymphatic Delivery of mRNA Vaccine to Potentiate Cancer Immunotherapy.
Zhang Miao, et al. Advanced materials (Deerfield Beach, Fla.) 2024 0 0. e2412654
scGraph2Vec: a deep generative model for gene embedding augmented by graph neural network and single-cell omics data.
Lin Shiqi, et al. GigaScience 2024 0 0.
Validation of administrative health data for the identification of endometriosis diagnosis.
Kiser A C, et al. Human reproduction (Oxford, England) 2024 0 0.
Adenoviral-vectored neoantigen vaccine augments hyperexpanded CD8 T cell control of tumor challenge in mice.
Dagotto Gabriel, et al. Journal for immunotherapy of cancer 2024 0 0. (12)
Developing a digital phenotype to subdivide adult immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network.
Leston Meredith, et al. Frontiers in immunology 2024 0 0. 1491565
Meningitis due to Gemella sp. in a patient with severe ENT conditions: case report and review of the literature.
Benhalima Ilyès, et al. Annals of clinical microbiology and antimicrobials 2024 0 0. (1) 106
More
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to cancer...more
Content Summary
Common Type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: